MSL3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.963400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.980400E-01
Normal-vs-Stage2
3.043400E-01
Normal-vs-Stage3
2.404200E-01
Normal-vs-Stage4
1.444040E-01
Stage1-vs-Stage2
8.136600E-01
Stage1-vs-Stage3
3.375800E-01
Stage1-vs-Stage4
7.307600E-01
Stage2-vs-Stage3
2.095200E-01
Stage2-vs-Stage4
5.312000E-01
Stage3-vs-Stage4
5.873800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.962400E-01
Normal-vs-AfricanAmerican
3.005000E-01
Normal-vs-Asian
2.826800E-01
Caucasian-vs-AfricanAmerican
9.689400E-01
Caucasian-vs-Asian
6.689200E-01
AfricanAmerican-vs-Asian
6.794000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.819000E-01
Normal-vs-Female
3.162200E-01
Male-vs-Female
4.911600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.829000E-01
Normal-vs-Age(41-60Yrs)
3.304800E-01
Normal-vs-Age(61-80Yrs)
2.839400E-01
Normal-vs-Age(81-100Yrs)
2.741600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.152400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.449400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.060800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.139800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.075500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.444800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.876800E-01
Normal-vs-Daily Drinker
2.677600E-01
Normal-vs-Weekly Drinker
2.863800E-01
Normal-vs-Occasional Drinker
2.755000E-01
Normal-vs-Social Drinker
3.219200E-01
Non Drinker-vs-Daily Drinker
5.140800E-01
Non Drinker-vs-Weekly Drinker
9.612800E-01
Non Drinker-vs-Occasional Drinker
6.955200E-01
Non Drinker-vs-Social Drinker
3.047200E-01
Daily Drinker-vs-Weekly Drinker
5.795200E-01
Daily Drinker-vs-Occasional Drinker
7.292400E-01
Daily Drinker-vs-Social Drinker
6.138100E-02
Weekly Drinker-vs-Occasional Drinker
7.616600E-01
Weekly Drinker-vs-Social Drinker
3.241600E-01
Occasional Drinker-vs-Social Drinker
8.499700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.352600E-01
Normal-vs-Grade 2
9.807200E-01
Normal-vs-Grade 3
9.855200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.713400E-01
Grade 1-vs-Grade 3
8.805600E-01
Grade 1-vs-Grade 4
9.352600E-01
Grade 2-vs-Grade 3
4.112600E-01
Grade 2-vs-Grade 4
9.807200E-01
Grade 3-vs-Grade 4
9.855200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.935200E-01
Normal-vs-NonDiabetic
2.837400E-01
Diabetic-vs-NonDiabetic
6.964200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.878600E-01
Normal-vs-NoPancreatitis
2.872400E-01
Pancreatitis-vs-NoPancreatitis
9.968000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.875400E-01
Normal-vs-N1
3.020200E-01
N0-vs-N1
4.775600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.514400E-01
Normal-vs-TP53-NonMutant
2.917200E-01
TP53-Mutant-vs-TP53-NonMutant
9.786300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
